Mgo One Seven LLC Bristol Myers Squibb CO Transaction History

Mgo One Seven LLC

$2.53 Billion
Q4 2024

A detailed history of Mgo One Seven LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mgo One Seven LLC holds 29,376 shares of BMY stock, worth $1.76 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

29,376

Previous 24,174 21.52%

Holding current value

$1.76 Million

Previous $1.25 Million 32.77%

% of portfolio

0.07%

Previous 0.06%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$51.92 - $59.94 $270,087 - $311,807	5,202 Added 21.52%	29,376 $1.66 Million
Q3 2024 Oct 15, 2024	SELL	$39.66 - $51.75 $10,033 - $13,092	-253 Reduced 1.04%	24,174 $1.25 Million
Q2 2024 Aug 07, 2024	BUY	$40.25 - $52.99 $65,688 - $86,479	1,632 Added 7.16%	24,427 $1.01 Million
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $47,164 - $53,475	983 Added 4.51%	22,795 $1.24 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $85,761 - $102,336	-1,769 Reduced 7.5%	21,812 $1.12 Million
Q3 2023 Nov 03, 2023	SELL	$57.89 - $64.73 $13,835 - $15,470	-239 Reduced 1.0%	23,581 $1.37 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $1.06 Million - $1.18 Million	-16,666 Reduced 41.16%	23,820 $1.52 Million
Q1 2023 May 08, 2023	BUY	$65.71 - $74.53 $1 Million - $1.14 Million	15,250 Added 60.43%	40,486 $2.81 Million
Q4 2022 Jan 25, 2023	SELL	$68.48 - $81.09 $48,209 - $57,087	-704 Reduced 2.71%	25,236 $0
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $339 - $200,475	2,609 Added 11.18%	25,940 $1.89 Million
Q2 2022 Aug 10, 2022	SELL	$72.62 - $79.98 $562,078 - $619,045	-7,740 Reduced 24.91%	23,331 $1.8 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $143,309 - $171,841	2,331 Added 8.11%	31,071 $2.27 Million
Q4 2021 Feb 09, 2022	BUY	$53.63 - $62.52 $647,367 - $754,678	12,071 Added 72.42%	28,740 $1.79 Million
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $73,489 - $86,083	-1,242 Reduced 6.93%	16,669 $974,000
Q2 2021 Jul 29, 2021	BUY	$61.91 - $67.42 $121,281 - $132,075	1,959 Added 12.28%	17,911 $1.2 Million
Q1 2021 Apr 29, 2021	BUY	$59.34 - $66.74 $82,660 - $92,968	1,393 Added 9.57%	15,952 $1.01 Million
Q4 2020 Jan 22, 2021	BUY	$57.74 - $65.43 $26,560 - $30,097	460 Added 3.26%	14,559 $903,000
Q3 2020 Oct 30, 2020	SELL	$57.43 - $63.64 $52,835 - $58,548	-920 Reduced 6.13%	14,099 $850,000
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $167,749 - $196,115	3,060 Added 25.59%	15,019 $883,000
Q1 2020 Apr 17, 2020	BUY	$46.4 - $67.43 $118,180 - $171,744	2,547 Added 27.06%	11,959 $666,000
Q4 2019 Jan 16, 2020	BUY	$49.21 - $64.19 $463,164 - $604,156	9,412 New	9,412 $604,000
Q1 2019 Apr 09, 2019	SELL	$45.12 - $53.8 $116,905 - $139,395	-2,591 Closed	0 $0
Q4 2018 Jan 24, 2019	BUY	$48.76 - $63.23 $126,337 - $163,828	2,591 New	2,591 $134,000
Q3 2018 Oct 09, 2018	SELL	$55.19 - $62.25 $99,949 - $112,734	-1,811 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $119 - $137	-2 Reduced 0.11%	1,811 $115,000
Q4 2017 Feb 16, 2018	BUY	$59.94 - $65.35 $108,671 - $118,479	1,813	1,813 $111,000

Others Institutions Holding BMY

# of Institutions

2,764

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $128B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.

Account